Revenues mean nothing. When they get FDA approval it will go 3 to 8 bucks. If you sell then you are beyond stupid. This is going 18 to 35 bucks a share. I've said it all along. They are going to corner a mult-billion dollar market. Tons of pharm companies are going to be bidding on this product. They will be talking about this stock on the OTC board for decades after the CEO sells the company. Their product is going to change the entire medical profession. I just can't believe how many tools out there still don't get it on this stock.
News 
Market Data 
Discover 
